Quotazioni in diretta
| Data | Ora | Fonte | Titolo |
|---|---|---|---|
| 15/5/2024 | 22:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 15/5/2024 | 22:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13/5/2024 | 15:00 | GLOBE | Chromocell To Present at Alliance Global Partner’s.. |
| 09/4/2024 | 14:30 | GLOBE | Chromocell Issues Letter to Stockholders from Chief.. |
| 21/3/2024 | 13:30 | GLOBE | Chromocell Announces Formal Launch of Eye Pain Treatment.. |
| 18/3/2024 | 15:00 | GLOBE | Chromocell Names Frank Knuettel as Chief Executive Officer,.. |
| 11/3/2024 | 14:00 | GLOBE | Chromocell to Present at Sidoti Virtual Investor Conference.. |
| 27/2/2024 | 14:00 | GLOBE | Benuvia Operations, LLC and Chromocell Therapeutics Corp... |
| 21/2/2024 | 22:47 | GLOBE | Chromocell Therapeutics Announces Closing of Initial Public.. |
| 16/2/2024 | 14:00 | GLOBE | Chromocell Therapeutics Announces Pricing of Upsized $6.6.. |
| Apertura: 2,00 | Min: 1,73 | Max: 2,00 |
| Chiusura: 1,75 |
|
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni |
|
ADVFN Network
|
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
